Canine genomics co. scores $75M in fundingJuly 29, 2021A canine genomics and biotechnology company hoping to increase the lifespan of dogs by three years within the next decade has raised $75 million in Series B funding.
SPONSORED CONTENTDilution Is the SolutionDiscover the most comprehensive line of therapeutic diets formulated to dilute urine and support urinary health + Learn More